Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 1
2003 2
2004 2
2005 1
2006 16
2007 25
2008 24
2009 25
2010 21
2011 29
2012 19
2013 32
2014 14
2015 3
2016 3
2017 3
2018 2
2019 4
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

203 results
Results by year
Filters applied: . Clear all
Page 1
Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma.
Quintás-Cardama A. Quintás-Cardama A. N Engl J Med. 2019 Jul 18;381(3):e6. doi: 10.1056/NEJMc1907520. N Engl J Med. 2019. PMID: 31314981 No abstract available.
Nilotinib.
Ostendorf BN, le Coutre P, Kim TD, Quintás-Cardama A. Ostendorf BN, et al. Among authors: quintas cardama a. Recent Results Cancer Res. 2014;201:67-80. doi: 10.1007/978-3-642-54490-3_3. Recent Results Cancer Res. 2014. PMID: 24756785 Review.
Nilotinib.
Quintás-Cardama A, Kim TD, Cataldo V, le Coutre P. Quintás-Cardama A, et al. Recent Results Cancer Res. 2010;184:103-17. doi: 10.1007/978-3-642-01222-8_8. Recent Results Cancer Res. 2010. PMID: 20072834 Review.
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.
Quintás-Cardama A, Vaddi K, Liu P, Manshouri T, Li J, Scherle PA, Caulder E, Wen X, Li Y, Waeltz P, Rupar M, Burn T, Lo Y, Kelley J, Covington M, Shepard S, Rodgers JD, Haley P, Kantarjian H, Fridman JS, Verstovsek S. Quintás-Cardama A, et al. Blood. 2010 Apr 15;115(15):3109-17. doi: 10.1182/blood-2009-04-214957. Epub 2010 Feb 3. Blood. 2010. PMID: 20130243 Free PMC article.
Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.
Brentjens RJ, Santos E, Nikhamin Y, Yeh R, Matsushita M, La Perle K, Quintás-Cardama A, Larson SM, Sadelain M. Brentjens RJ, et al. Among authors: quintas cardama a. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5426-35. doi: 10.1158/1078-0432.CCR-07-0674. Epub 2007 Sep 12. Clin Cancer Res. 2007. PMID: 17855649 Free article.
Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera.
Quintás-Cardama A, Kantarjian H, Manshouri T, Luthra R, Estrov Z, Pierce S, Richie MA, Borthakur G, Konopleva M, Cortes J, Verstovsek S. Quintás-Cardama A, et al. J Clin Oncol. 2009 Nov 10;27(32):5418-24. doi: 10.1200/JCO.2009.23.6075. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826111 Free PMC article. Clinical Trial.
What CAR Will Win the CD19 Race?
Quintás-Cardama A. Quintás-Cardama A. Mol Cancer Ther. 2019 Mar;18(3):498-506. doi: 10.1158/1535-7163.MCT-18-1070. Mol Cancer Ther. 2019. PMID: 30824581 Free article. Review.
203 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page